Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Pilot Phase 1, Randomized, Single-Dose, 6-Sequences, 3-Period, Crossover Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual Tablet) and Intravenous Midazolam or Ketamine in Healthy Volunteers


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04485702

Organisation Name: Melt Pharmaceuticals

Overal Status: Completed

Start Date: July 20, 2020

Last Update: February 23, 2021

Lead Sponsor: Melt Pharmaceuticals

Brief Summary: Comparative Bioavailability study testing MELT-100 (midazolam and ketamine sublingual tablet) and IV midazolam or ketamine in healthy volunteers

Conditions:
  • Healthy Volunteers


Total execution time in seconds: 0.15506601333618